(Q43189245)

15 November 2017

Ecstasy and neurodegeneration. Tablets often contain substances in addition to, or instead of, ecstasy... (English)

1 reference

15 November 2017

1 reference

A R Winstock

1

1 reference

15 November 2017

L A King

series ordinal

2

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

15 November 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

The BMJ

1 reference

15 November 2017

313

1 reference

15 November 2017

7054

1 reference

15 November 2017

423-424

1 reference

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

15 November 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351818

The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

25 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351818

Ecstasy and neurodegeneration

25 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351818

Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8761240

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.313.7054.423B

1 reference

15 November 2017

1 reference

15 November 2017

PubMed publication ID

8761240

1 reference